Advanced MRI Assessment during Dendritic Cell Immunotherapy Added to Standard Treatment Against Glioblastoma

Advanced MRI Assessment during Dendritic Cell Immunotherapy Added to Standard Treatment Against Glioblastoma

Evaluating changes induced by immunotherapies (IT) on conventional magnetic resonance imaging (MRI) is difficult because those treatments may produce inflammatory responses. To explore the potential contribution of advanced MRI to distinguish pseudoprogression (PsP) and true tumor progression (TTP),...

Full description

Bibliographic Details
Main Authors: Valeria Cuccarini, Domenico Aquino, Andrea Gioppo, Elena Anghileri, Serena Pellegatta, Carla Schettino, Federica Mazzi, Gaetano Finocchiaro, Maria Grazia Bruzzone, Marica Eoli
Format: Article
Language:English
Published: MDPI AG 2019-11-01
Series:Journal of Clinical Medicine
Subjects:
glioblastoma
immunotherapy
pseudoprogression
dsc-mri
dwi-mri
Online Access:https://www.mdpi.com/2077-0383/8/11/2007

Internet

https://www.mdpi.com/2077-0383/8/11/2007

Similar Items